Fibrosclerosis of breast. Cystic mastopathy with epithelial proliferation
Conditions
Interventions
Intervention 1: Control group will receive vitamin E pearl 200 IU twice a day for two month. Intervention 2: Intervention group will receive Flaxseed oil pearl (contain 350 mg alpha linoleic acid) tw
Placebo
Treatment - Drugs
Control group will receive vitamin E pearl 200 IU twice a day for two month.
Intervention group will receive Flaxseed oil pearl (contain 350 mg alpha linoleic acid) twice a day.
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
75 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 20-50 years; willingness to participate in study; existence of lump or pain in breast examination; no willingness for pregnancy; having no malignancy Exclusion criteria: sensitivity to Flaxseed oil; not willing to continue the study; breast- feeding women
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast pain severity. Timepoint: One month before intervention, first month after intervention, second month after intervention. Method of measurement: Cardiff chart, VAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast nodularity. Timepoint: One month before, first and second month after intervention. Method of measurement: Lacknow-Cardiff scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Shahram Ala
Mazandaran University of Medical Sciences
Outcome results
None listed